Logo image of UTME

UTIME LTD (UTME) Stock Fundamental Analysis

NASDAQ:UTME - Nasdaq - KYG9411M1087 - Common Stock - Currency: USD

0.478  -0.01 (-1.42%)

After market: 0.478 0 (0%)

Fundamental Rating

0

Taking everything into account, UTME scores 0 out of 10 in our fundamental rating. UTME was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. UTME may be in some trouble as it scores bad on both profitability and health. UTME is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year UTME has reported negative net income.
In the past year UTME has reported a negative cash flow from operations.
In the past 5 years UTME always reported negative net income.
UTME had negative operating cash flow in 4 of the past 5 years.
UTME Yearly Net Income VS EBIT VS OCF VS FCFUTME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

UTME has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UTME Yearly ROA, ROE, ROICUTME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

With a Gross Margin value of 13.01%, UTME is not doing good in the industry: 70.40% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of UTME has grown nicely.
The Profit Margin and Operating Margin are not available for UTME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.36%
GM growth 5Y14.27%
UTME Yearly Profit, Operating, Gross MarginsUTME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30 -40

More info and screens

0

2. Health

2.1 Basic Checks

UTME does not have a ROIC to compare to the WACC, probably because it is not profitable.
UTME has more shares outstanding than it did 1 year ago.
The number of shares outstanding for UTME has been increased compared to 5 years ago.
UTME has a worse debt/assets ratio than last year.
UTME Yearly Shares OutstandingUTME Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
UTME Yearly Total Debt VS Total AssetsUTME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

UTME has an Altman-Z score of -0.71. This is a bad value and indicates that UTME is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.71, UTME is not doing good in the industry: 84.80% of the companies in the same industry are doing better.
UTME has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
UTME has a worse Debt to Equity ratio (1.38) than 92.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Altman-Z -0.71
ROIC/WACCN/A
WACC10.98%
UTME Yearly LT Debt VS Equity VS FCFUTME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 0.96 indicates that UTME may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.96, UTME is doing worse than 91.20% of the companies in the same industry.
UTME has a Quick Ratio of 0.96. This is a bad value and indicates that UTME is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, UTME is doing worse than 81.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.9
UTME Yearly Current Assets VS Current LiabilitesUTME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

UTME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.23%.
UTME shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.81%.
The Revenue for UTME have been decreasing by -11.85% on average. This is quite bad
EPS 1Y (TTM)-62.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.04%
Revenue 1Y (TTM)-12.81%
Revenue growth 3Y1.27%
Revenue growth 5Y-11.85%
Sales Q2Q%-27.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UTME Yearly Revenue VS EstimatesUTME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UTME. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UTME Price Earnings VS Forward Price EarningsUTME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UTME Per share dataUTME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UTME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UTIME LTD

NASDAQ:UTME (9/1/2023, 8:00:02 PM)

After market: 0.478 0 (0%)

0.478

-0.01 (-1.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners0.52%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.49M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 1.08
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-1.3
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS3.3
BVpS0.44
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.01%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.36%
GM growth 5Y14.27%
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.05%
Cap/Sales 0.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.9
Altman-Z -0.71
F-Score3
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)80.3%
Cap/Depr(5y)214.37%
Cap/Sales(3y)1.49%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-62.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.81%
Revenue growth 3Y1.27%
Revenue growth 5Y-11.85%
Sales Q2Q%-27.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-148%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.45%
OCF growth 3YN/A
OCF growth 5YN/A